These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2904349)

  • 1. Deletions in human chromosome arms 11p and 13q in primary hepatocellular carcinomas.
    Wang HP; Rogler CE
    Cytogenet Cell Genet; 1988; 48(2):72-8. PubMed ID: 2904349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No evidence for loss of alleles at 11p in HBV negative hepatocellular carcinomas.
    Kiechle-Schwarz M; Scherer G; Kovacs G
    Genes Chromosomes Cancer; 1990 Mar; 1(4):312-4. PubMed ID: 1980606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of somatic heterozygosity in hepatocellular carcinoma.
    Walker GJ; Hayward NK; Falvey S; Cooksley WG
    Cancer Res; 1991 Aug; 51(16):4367-70. PubMed ID: 1678314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent loss of heterozygosity on chromosomes 16 and 4 in human hepatocellular carcinoma.
    Zhang WD; Hirohashi S; Tsuda H; Shimosato Y; Yokota J; Terada M; Sugimura T
    Jpn J Cancer Res; 1990 Feb; 81(2):108-11. PubMed ID: 1970554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of allelic loss on arms of chromosomes 13q, 16q and 17p in the advanced stages of human hepatocellular carcinoma.
    Nishida N; Fukuda Y; Kokuryu H; Sadamoto T; Isowa G; Honda K; Yamaoka Y; Ikenaga M; Imura H; Ishizaki K
    Int J Cancer; 1992 Jul; 51(6):862-8. PubMed ID: 1322376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive allelotype study of hepatocellular carcinoma: potential differences in pathways to hepatocellular carcinoma between hepatitis B virus-positive and -negative tumors.
    Okabe H; Ikai I; Matsuo K; Satoh S; Momoi H; Kamikawa T; Katsura N; Nishitai R; Takeyama O; Fukumoto M; Yamaoka Y
    Hepatology; 2000 May; 31(5):1073-9. PubMed ID: 10796882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of heterozygosity on chromosome 16 in hepatocellular carcinoma.
    Sakai K; Nagahara H; Abe K; Obata H
    J Gastroenterol Hepatol; 1992; 7(3):288-92. PubMed ID: 1351753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma.
    Tsuda H; Zhang WD; Shimosato Y; Yokota J; Terada M; Sugimura T; Miyamura T; Hirohashi S
    Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6791-4. PubMed ID: 2168560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic changes in human adrenocortical carcinomas.
    Yano T; Linehan M; Anglard P; Lerman MI; Daniel LN; Stein CA; Robertson CN; LaRocca R; Zbar B
    J Natl Cancer Inst; 1989 Apr; 81(7):518-23. PubMed ID: 2564050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Loss of heterozygosity in hepatocellular carcinoma].
    Takahashi K; Kudo J; Ishibashi H; Niho Y
    Nihon Rinsho; 1993 Feb; 51(2):370-4. PubMed ID: 8096550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung.
    Yokota J; Wada M; Shimosato Y; Terada M; Sugimura T
    Proc Natl Acad Sci U S A; 1987 Dec; 84(24):9252-6. PubMed ID: 2892196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma.
    Buetow KH; Murray JC; Israel JL; London WT; Smith M; Kew M; Blanquet V; Brechot C; Redeker A; Govindarajah S
    Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8852-6. PubMed ID: 2573067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity at chromosomal regions 3p and 13q in non-small-cell carcinoma of the lung represents low-frequency events.
    Becker D; Sahin AA
    Genomics; 1989 Jan; 4(1):97-100. PubMed ID: 2536637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion mapping of chromosome 11 in carcinoma of the bladder.
    Shaw ME; Knowles MA
    Genes Chromosomes Cancer; 1995 May; 13(1):1-8. PubMed ID: 7541638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological significance of loss of heterozygosity on chromosome 13q in hepatocellular carcinoma.
    Wong CM; Lee JM; Lau TC; Fan ST; Ng IO
    Clin Cancer Res; 2002 Jul; 8(7):2266-72. PubMed ID: 12114430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas.
    Slagle BL; Zhou YZ; Butel JS
    Cancer Res; 1991 Jan; 51(1):49-54. PubMed ID: 1670994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for the presence of two tumour-suppressor genes for hepatocellular carcinoma on chromosome 13q.
    Kuroki T; Fujiwara Y; Nakamori S; Imaoka S; Kanematsu T; Nakamura Y
    Br J Cancer; 1995 Aug; 72(2):383-5. PubMed ID: 7640222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent loss of heterozygosity on chromosome 22 in hepatocellular carcinoma.
    Takahashi K; Kudo J; Ishibashi H; Hirata Y; Niho Y
    Hepatology; 1993 May; 17(5):794-9. PubMed ID: 8387946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletions of chromosome 13q, mutations in Retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma.
    Zhang X; Xu HJ; Murakami Y; Sachse R; Yashima K; Hirohashi S; Hu SX; Benedict WF; Sekiya T
    Cancer Res; 1994 Aug; 54(15):4177-82. PubMed ID: 8033150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelotype study of primary hepatocellular carcinoma.
    Fujimori M; Tokino T; Hino O; Kitagawa T; Imamura T; Okamoto E; Mitsunobu M; Ishikawa T; Nakagama H; Harada H
    Cancer Res; 1991 Jan; 51(1):89-93. PubMed ID: 1670995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.